Today’s question!

Check out the answer on the next slide along with its explanation.

@ash.edu.hematology.org @rarediseasectn.bsky.social @rarediseasesint.bsky.social @bsochaem.bsky.social @vjhemonc.bsky.social #Erythrocytosis #Hematology #MyeloproliferativeDisorders #SecondaryErythrocytosis #EPO

Today’s question!

Check out the answer on the next slide along with its explanation.

#NonPVErythrocytosis #Erythrocytosis #Hematology #MyeloproliferativeDisorders #SecondaryErythrocytosis @vjhemonc.bsky.social @bsochaem.bsky.social @ash.edu.hematology.org

Today’s first question highlights a key distinguishing feature of TEMPI syndrome in clinical practice.

#JAK2NegativeErythrocytosis #NonPVErythrocytosis #Erythrocytosis #Hematology #MyeloproliferativeDisorders #SecondaryErythrocytosis #EPO #Hypoxia #GermlineMutations #ClinicalHematology

This Month on HemeHub: JAK2 Unmutated Erythrocytosis

Join us as we highlight essential insights on the diagnosis, management, and treatment of JAK2 Unmutated Erythrocytosis.

#Hematology #BloodDisorders #SecondaryErythrocytosis @bsochaem.bsky.social @vjhemonc.bsky.social @ash.edu.hematology.org